The anti-dilution clause is madness. I can't see how it's a good thing for CQT share holders. But then again maybe this simple duck is missing something?
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
